Repository logo
 

Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death.

Accepted version
Peer-reviewed

Change log

Authors

Hughes, Craig 
Choi, Minee L 
Yi, Jee-Hyun 
Kim, Seung-Chan 
Drews, Anna 

Abstract

The molecular events causing memory loss and neuronal cell death in Alzheimer's disease (AD) over time are still unknown. Here we found that picomolar concentrations of soluble oligomers of synthetic beta amyloid (Aβ42) aggregates incubated with BV2 cells or rat astrocytes caused a sensitised response of Toll-like receptor 4 (TLR4) with time, leading to increased production of TNF-α. Aβ aggregates caused long term potentiation (LTP) deficit in hippocampal slices and predominantly neuronal cell death in co-cultures of astrocytes and neurons, which was blocked by TLR4 antagonists. Soluble Aβ aggregates cause LTP deficit and neuronal death via an autocrine/paracrine mechanism due to TLR4 signalling. These findings suggest that the TLR4-mediated inflammatory response may be a key pathophysiological process in AD.

Description

Keywords

Amyloid beta-Peptides, Animals, Animals, Newborn, Cell Death, Cells, Cultured, Embryo, Mammalian, Long-Term Potentiation, Male, Mice, Neurons, Protein Aggregates, Protein Aggregation, Pathological, Rats, Rats, Sprague-Dawley, Rats, Wistar, Signal Transduction, Toll-Like Receptor 4

Journal Title

Commun Biol

Conference Name

Journal ISSN

2399-3642
2399-3642

Volume Title

3

Publisher

Springer Science and Business Media LLC

Rights

All rights reserved
Sponsorship
European Research Council (669237)
Medical Research Council (MC_G1000734)
Wellcome Trust (108045/Z/15/Z)
This work was supported by ARUK. AD was financed by a Herchel Smith Postdoctoral Fellowship. DK acknowledges funding from the Royal Society and ERC Advanced Grant (669237). SG acknowledges funding by Wellcome, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. KC acknowledges funding by the UK Dementia Research Institute